Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:31 PM
Ignite Modification Date:
2025-12-24 @ 1:31 PM
NCT ID:
NCT07129395
Eligibility Criteria:
Inclusion Criteria:
* Anticoagulated CCHMC patients ages 0 to 29.9 years and their caregivers (where applicable for patients \< 18 years)
* Able to provide informed consent
* Duration of anticoagulation planned for the outpatient setting is 4 weeks or longer
* Willing and able to participate in telephone and in person study visits
* For patients \< 18 years, both patient and caregiver agree to participate
Exclusion Criteria:
* Unwilling or unable to provide informed consent
* Duration of anticoagulation is planned for \< 4 weeks in the outpatient setting
* Anticoagulant drug will not fit into the EAMD
* Unable to participate in telephone study visit
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
29 Years
Study:
NCT07129395
Study Brief:
Protocol Section:
NCT07129395